Related Experiment Video
Updated: Feb 24, 2026
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
1.1K
Neurocognitive functioning and cannabis use in schizophrenia.
1Shalvata Mental Health Center, POB 94, Hod Hasharon, Israel. aviv@segev.name
Current Pharmaceutical Design
|June 22, 2012
Summary
Cannabis use in schizophrenia patients shows mixed cognitive effects. While some studies indicate improved cognitive function, others find no difference or even deficits, highlighting the need for methodologically rigorous research.
Area of Science:
- Neuroscience
- Psychiatry
- Addiction Medicine
Background:
- Schizophrenia is often accompanied by cognitive impairment.
- Cannabis use is common in schizophrenia patients.
- The endocannabinoid system, affected by cannabis, plays a role in neurotransmission and may be altered in schizophrenia.
Purpose of the Study:
- To review existing literature on the cognitive effects of cannabis in schizophrenia patients.
- To compare cognitive functioning between cannabis-using and non-using schizophrenia patients.
Main Methods:
- Systematic review of 19 studies.
- Comparison of cognitive domains including memory, attention, executive functions, and processing speed.
- Analysis of studies examining cannabis use versus non-use in schizophrenia.
Main Results:
- 11 studies reported better cognitive function in cannabis-using schizophrenia patients.
- 5 studies found no significant difference.
- 3 studies indicated poorer cognitive function in cannabis users.
Conclusions:
- Inconsistent findings suggest significant methodological variations across studies.
- Patient selection, control groups, cognitive assessments, and cannabis use measures impact results.
- Further research with standardized methodologies is needed to clarify cannabis's cognitive impact in schizophrenia.
Related Concept Videos
01:30Negative and Cognitive Symptoms of Schizophrenia
748
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
748
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
974
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
974
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
718
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
718
01:29Biological Causes of Schizophrenia
780
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
780
01:17Schizophrenia
1.3K
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
1.3K
01:29Psychological and Sociocultural Causes of Schizophrenia
697
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
697